OFFICIAL PUBLICATION OF

by its subsidiary APPco

Panadol Osteo referral: a first for the Minister

Janet Doyle 11/01/2016

Sussan Ley at desk (6Th community pharmacy agreement talks)

It is the first time Health Minister Sussan Ley has referred a company to the ACCC due to the “unique” circumstances surrounding the price rise for Panadol Osteo, a spokesman for the Minister told the AJP. The spokesperson says the Minister is also concerned about GSK’s market dominance and “misleading claims” and “justification” for the price

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Panadol Osteo referral: a first for the Minister

Previous Heart Foundation gives the Tick the flick

Next Panadol Osteo, admit it was a mistake: Guild

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Heart Foundation gives the Tick the flick

Next Panadol Osteo, admit it was a mistake: Guild

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.